Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeBiotech

      Biotech

      Zymeworks Announces Participation in Upcoming Investor Conferences
      Biotech

      Zymeworks Announces Participation in Upcoming Investor Conferences

      August 11, 2026
      Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
      Biotech

      Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

      August 10, 2026
      Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027
      Biotech

      Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027

      August 10, 2026
      Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
      Biotech

      Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

      August 10, 2026
      Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering
      Biotech

      Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering

      August 7, 2026
      Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website
      Biotech

      Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

      August 6, 2026
      Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
      Biotech

      Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

      August 6, 2026
      Braveheart Bio Announces Pricing of Upsized Initial Public Offering
      Biotech

      Braveheart Bio Announces Pricing of Upsized Initial Public Offering

      August 6, 2026
      Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results  and Provides Business Update
      Biotech

      Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results and Provides Business Update

      August 6, 2026
      Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
      Biotech

      Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

      August 5, 2026
      « 1 … 12 13 14 15 16 … 212 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026